Cargando…

Salient features of mesenchymal stem cells—implications for Ewing sarcoma modeling

Despite a heightened appreciation of the many defining molecular aberrations in Ewing sarcoma, the cooperative genetic environment and permissive cell of origin essential for EWS/ETS-mediated oncogenesis remain elusive. Consequently, inducible animal and in vitro models of Ewing sarcoma from a nativ...

Descripción completa

Detalles Bibliográficos
Autores principales: Monument, Michael J., Bernthal, Nicholas M., Randall, R. Lor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580960/
https://www.ncbi.nlm.nih.gov/pubmed/23443465
http://dx.doi.org/10.3389/fonc.2013.00024
_version_ 1782260352588709888
author Monument, Michael J.
Bernthal, Nicholas M.
Randall, R. Lor
author_facet Monument, Michael J.
Bernthal, Nicholas M.
Randall, R. Lor
author_sort Monument, Michael J.
collection PubMed
description Despite a heightened appreciation of the many defining molecular aberrations in Ewing sarcoma, the cooperative genetic environment and permissive cell of origin essential for EWS/ETS-mediated oncogenesis remain elusive. Consequently, inducible animal and in vitro models of Ewing sarcoma from a native cellular context are unable to fully recapitulate malignant transformation. Despite these shortcomings, human, and murine mesenchymal stem cells (MSCs) are the closest working in vitro systems available. MSCs are tolerant of ectopic EWS/FLI expression, which is accompanied by a molecular signature most similar to Ewing sarcoma. Whether MSCs are the elusive cell of origin or simply a tolerant platform of the EWS/FLI transcriptome, these cells have become an excellent molecular tool to investigate and manipulate oncogenesis in Ewing sarcoma. Our understanding of the biological complexity and heterogeneity of human MSCs (hMSCs) has increased substantially over time and as such, appreciation and utilization of these salient complexities may greatly enhance the efficient use of these cells as surrogate models for Ewing sarcoma tumorigenesis.
format Online
Article
Text
id pubmed-3580960
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-35809602013-02-26 Salient features of mesenchymal stem cells—implications for Ewing sarcoma modeling Monument, Michael J. Bernthal, Nicholas M. Randall, R. Lor Front Oncol Oncology Despite a heightened appreciation of the many defining molecular aberrations in Ewing sarcoma, the cooperative genetic environment and permissive cell of origin essential for EWS/ETS-mediated oncogenesis remain elusive. Consequently, inducible animal and in vitro models of Ewing sarcoma from a native cellular context are unable to fully recapitulate malignant transformation. Despite these shortcomings, human, and murine mesenchymal stem cells (MSCs) are the closest working in vitro systems available. MSCs are tolerant of ectopic EWS/FLI expression, which is accompanied by a molecular signature most similar to Ewing sarcoma. Whether MSCs are the elusive cell of origin or simply a tolerant platform of the EWS/FLI transcriptome, these cells have become an excellent molecular tool to investigate and manipulate oncogenesis in Ewing sarcoma. Our understanding of the biological complexity and heterogeneity of human MSCs (hMSCs) has increased substantially over time and as such, appreciation and utilization of these salient complexities may greatly enhance the efficient use of these cells as surrogate models for Ewing sarcoma tumorigenesis. Frontiers Media S.A. 2013-02-25 /pmc/articles/PMC3580960/ /pubmed/23443465 http://dx.doi.org/10.3389/fonc.2013.00024 Text en Copyright © 2013 Monument, Bernthal and Randall. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc.
spellingShingle Oncology
Monument, Michael J.
Bernthal, Nicholas M.
Randall, R. Lor
Salient features of mesenchymal stem cells—implications for Ewing sarcoma modeling
title Salient features of mesenchymal stem cells—implications for Ewing sarcoma modeling
title_full Salient features of mesenchymal stem cells—implications for Ewing sarcoma modeling
title_fullStr Salient features of mesenchymal stem cells—implications for Ewing sarcoma modeling
title_full_unstemmed Salient features of mesenchymal stem cells—implications for Ewing sarcoma modeling
title_short Salient features of mesenchymal stem cells—implications for Ewing sarcoma modeling
title_sort salient features of mesenchymal stem cells—implications for ewing sarcoma modeling
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580960/
https://www.ncbi.nlm.nih.gov/pubmed/23443465
http://dx.doi.org/10.3389/fonc.2013.00024
work_keys_str_mv AT monumentmichaelj salientfeaturesofmesenchymalstemcellsimplicationsforewingsarcomamodeling
AT bernthalnicholasm salientfeaturesofmesenchymalstemcellsimplicationsforewingsarcomamodeling
AT randallrlor salientfeaturesofmesenchymalstemcellsimplicationsforewingsarcomamodeling